$120.18
1.060.89%
At close: -
$123.04
2.862.38%
After Hours: 4:14 PM EDT
Comments
Loading...
Latest Neurocrine Biosciences Stock News | NASDAQ:NBIX | Benzinga
Get the latest news on Neurocrine Biosciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Neurocrine Biosciences performance
Categories: All
Friday, May 23, 2025
Friday, May 16, 2025
Thursday, May 15, 2025
Wednesday, May 14, 2025
Thursday, May 08, 2025
Tuesday, May 06, 2025
- Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
- Piper Sandler Reiterates Overweight on Neuroc...
- RBC Capital Maintains Outperform on Neurocrin...
- Guggenheim Maintains Buy on Neurocrine Biosci...
- FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
- BMO Capital Maintains Market Perform on Neuro...
- UBS Maintains Buy on Neurocrine Biosciences, ...
- What 19 Analyst Ratings Have To Say About Neurocrine Biosciences
- Canaccord Genuity Maintains Buy on Neurocrine...
- Neurocrine Biosciences shares are trading hig...
- Needham Maintains Buy on Neurocrine Bioscienc...
